About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 5,841–5,850 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 5,704 |
EUROPEAN SPINE JOURNAL EUR SPINE J |
0940-6719 1432-0932 |
2.700 | 3.000 | Q2 | 36/139 | SPRINGER |
| 5,704 |
Evolving Systems EVOL SYST-GER |
1868-6478 1868-6486 |
2.700 | 2.800 | Q3 | 111/204 | SPRINGER HEIDELBERG |
| 5,704 |
EXPERIMENTAL BIOLOGY AND MEDICINE EXP BIOL MED |
1535-3702 1535-3699 |
2.700 | 3.400 | Q3 | 98/195 | FRONTIERS MEDIA SA |
| 5,704 |
EXPERIMENTAL EYE RESEARCH EXP EYE RES |
0014-4835 1096-0007 |
2.700 | 3.300 | Q2 | 26/98 | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| 5,704 |
EXPERT OPINION ON EMERGING DRUGS EXPERT OPIN EMERG DR |
1472-8214 1744-7623 |
2.700 | 2.700 | Q2 | 164/352 | TAYLOR & FRANCIS LTD |
| 5,704 |
EXPERT OPINION ON PHARMACOTHERAPY EXPERT OPIN PHARMACO |
1465-6566 1744-7666 |
2.700 | 3.000 | Q2 | 164/352 | TAYLOR & FRANCIS LTD |
| 5,704 |
Expert Review of Medical Devices EXPERT REV MED DEVIC |
1743-4440 1745-2422 |
2.700 | 3.100 | Q3 | 69/124 | TAYLOR & FRANCIS LTD |
| 5,704 |
Expert Review of Respiratory Medicine EXPERT REV RESP MED |
1747-6348 1747-6356 |
2.700 | 3.200 | Q2 | 47/108 | TAYLOR & FRANCIS LTD |
| 5,704 |
Facets FACETS |
2371-1671 2371-1671 |
2.700 | 3.100 | Q2 | 42/135 | CANADIAN SCIENCE PUBLISHING |
| 5,704 |
FEMS YEAST RESEARCH FEMS YEAST RES |
1567-1356 1567-1364 |
2.700 | 2.600 | Q3 | 17/32 | OXFORD UNIV PRESS |